XOS
Q4 2026 EPS Estimate
$-0.45
Nov 12, 2026 · Reports after close
Revenue Estimate
$15M

Analyst Sentiment

Wall St. Consensus
Hold
6 analysts·Limited coverage
50
Score
1 Buy (17%)4 Hold (67%)1 Sell (16%)
Rating Breakdown
Strong Buy
00%
Buy
117%
Hold
467%
Sell
117%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.40
-31.8%
Consensus
$9.00
+155.7%
Bull
$16.00
+354.5%
12-Month Target Range6 analysts
$2.40$9.00$16.00
Current $3.52Consensus
Current Price
$3.52
Upside to Consensus
$5.48

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+37.30%
EPS
FY2028
Rev+44.16%
EPS
FY2029
Rev+4.60%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$40M$54M$78M$82M
Low$37M$54M$77M$81M
High$42M$55M$79M$83M
EBITDA Avg$-18M$-25M$-35M$-37M
Low$-19M$-25M$-36M$-37M
High$-17M$-24M$-35M$-37M
EBIT Avg$-19M$-26M$-38M$-40M
Low$-21M$-27M$-39M$-40M
High$-18M$-26M$-38M$-40M
Net Income Avg$-19M$-18M$-18M
Low$-19M$-18M$-18M
High$-18M$-18M$-18M
EPS Avg$-1.99$-1.93$-1.91
Low$-2.01$-1.95$-1.93
High$-1.97$-1.91$-1.89
Analysts (Rev / EPS)1 / 11 / 11 / 11 /
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$15M$9M$10M$18M$18M$9M
Low$14M$6M$9M$16M$16M$8M
High$16M$11M$11M$19M$19M$10M
EBITDA Avg$-7M$-4M$-4M$-8M$-8M$-4M
Low$-7M$-5M$-5M$-9M$-9M$-4M
High$-6M$-3M$-4M$-7M$-7M$-4M
EBIT Avg$-7M$-4M$-5M$-9M$-9M$-4M
Low$-8M$-6M$-5M$-9M$-9M$-5M
High$-7M$-3M$-4M$-8M$-8M$-4M
Net Income Avg$-6M$-7M$-7M$-5M$-5M$-7M
Low$-6M$-8M$-8M$-6M$-6M$-8M
High$-5M$-6M$-6M$-5M$-5M$-6M
EPS Avg$-0.45$-0.56$-0.55$-0.42$-0.41$-0.55
Low$-0.50$-0.62$-0.61$-0.47$-0.46$-0.61
High$-0.40$-0.50$-0.49$-0.37$-0.36$-0.49
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Aug 16, 2024D.A. Davidson
Xos downgraded to Neutral from Buy at DA Davidson
Target:$9.00
+71.4%from $5.25
May 16, 2024Northland Securities
Northland Reiterates Outperform Rating on XOS Inc. (XOS)
Target:$16.00
+84.3%from $8.68
Apr 1, 2024D.A. Davidson
Xos upgraded to Buy from Neutral at DA Davidson
Target:$17.00
+66.0%from $10.24
Nov 14, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Xos, Lowers Price Target to $2.4
Target:$2.40
+150.0%from $0.96
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.